Edition:
United Kingdom

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

25.03USD
17 May 2019
Change (% chg)

$-0.63 (-2.46%)
Prev Close
$25.66
Open
$25.34
Day's High
$25.72
Day's Low
$24.93
Volume
349,391
Avg. Vol
517,921
52-wk High
$28.67
52-wk Low
$12.80

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease... (more)

Overall

Beta: 3.76
Market Cap(Mil.): $4,717.31
Shares Outstanding(Mil.): 122.40
Dividend: --
Yield (%): --

Financials

  ACAD.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.53 -- --
ROI: -74.14 8.91 13.82
ROE: -74.18 10.05 15.24

Earnings vs. Estimates